Products

Insider Intelligence delivers leading-edge research to clients in a variety of forms, including full-length reports and data visualizations to equip you with actionable takeaways for better business decisions.
Reports
In-depth analysis, benchmarks and shorter spotlights on digital trends.
Learn More
Forecasts
Interactive projections with 10k+ metrics on market trends, & consumer behavior.
Learn More
Charts
Proprietary data and over 3,000 third-party sources about the most important topics.
Learn More
Industry KPIs
Industry benchmarks for the most important KPIs in digital marketing, advertising, retail and ecommerce.
Learn More
Briefings
Client-only email newsletters with analysis and takeaways from the daily news.
Learn More
Analyst Access Program
Exclusive time with the thought leaders who craft our research.
Learn More

About Insider Intelligence

Our goal at Insider Intelligence is to unlock digital opportunities for our clients with the world’s most trusted forecasts, analysis, and benchmarks. Spanning five core coverage areas and dozens of industries, our research on digital transformation is exhaustive.
Our Story
Learn more about our mission and how Insider Intelligence came to be.
Learn More
Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Contact Us
Speak to a member of our team to learn more about Insider Intelligence.
Contact Us
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Advertising & Sponsorship Opportunities
Reach an engaged audience of decision-makers.
Learn More
Events
Browse our upcoming and past webinars and other events.
Learn More
Podcasts
Tune in to eMarketer's daily, weekly, and monthly podcasts.
Learn More

Health

Diabetes drug makers come under gov’t pressure: Big Pharma reacts to Biden administration push for limits on insulin prices. A majority of consumers—and employers—are cheering on cost pressures.

On today's episode, we discuss what omnichannel healthcare should look like, how patients are using social media to find health information, and why physicians don't want to review their patients' wearable data. "In Other News," we talk about what will happen moving forward regarding patient health information being shared for advertising purposes and why Best Buy is teaming up with Atrium Health. Tune in to the discussion with our analysts Rajiv Leventhal and Lisa Phillips.

Consumers see the potential of AI in clinical care: Patients’ comfort levels with AI in healthcare are mixed, but many are bullish on the tech’s ability to improve outcomes and reduce medical errors.

How consumers shop for doctors online: A new Patient Pop survey shows that finding a healthcare provider online is a lot like picking a restaurant or buying shoes. We dig into what they’re looking for before booking a doc.

WeightWatchers enters the Rx business for obesity: Its acquisition of medication-based weight loss program Sequence signals an emerging digital health market trend—but consumers must be cautious of telehealth startups' claims.

Amazon, One Medical, and BetterHelp targeted by the FTC: The federal agency issued a $7.8 million fine over use of patient health data. But it’s also looking for deceptive promises of privacy.

Walmart boosts healthcare to trickle down to its bottom line: It’s adding 28 clinics in 2024 and has new partnerships to address health inequities. The moves could lure more shoppers to higher-margin products, like prescription and OTC medications.

On today's episode, we discuss whether it's time for Google to spin off YouTube, how people feel about targeted ads, what consumers think about using AR to shop, what an in-car TikTok app might look like, the US Supreme Court examining Section 230, paid health leave in the US versus the world, and more. Tune in to the discussion with our analysts Blake Droesch, Evelyn Mitchell, and Paul Verna.

Across generations, the majority of US adults are concerned about the privacy of their health data within smartphone apps, according to Morning Consult. While the percentage of those with concerns has declined for all except Gen Z since 2021, older adults are still more likely to have this worry.

Hims & Hers defies digital health market odds: The D2C healthcare company grew revenues and membership—and unlike competitors, it’s increasing its marketing and advertising spend.

Patients use digital health tools, but don’t trust tech: Consumers say they don’t trust the very companies whose digital health tools they’re using. What gives?

Apple is making strides with a secret CGM project: The addition of a blood glucose monitor to the Apple Watch will drive sales beyond the diabetes patient pool to the “worried well.”

On today's episode, we discuss the significance of Amazon buying a primary care network, how ChatGPT did when it took the US Medical Licensing Exam, and what an Apple mixed reality headset could do to treat pain. "In Other News," we talk about health information being shared for advertising purposes and what to make of CVS buying Oak Street Health. Tune in to the discussion with our analysts Lisa Phillips and Rajiv Leventhal.

2 in 3 US adults are mobile health app users: Two surveys show how much consumers are turning to health apps for fitness and wellness. What’s driving the growth?

Social media influences patients and providers: Medical professionals can change their view of medications and treatments based on social media content. Pharma marketers, take notice.

Virtual nursing programs rise as need for travel nurses wanes: Staffing challenges are still keeping hospital CEOs up at night, giving rise to digital workforce support.

Olive’s problems aren’t AI’s problems: One of healthcare’s most hyped-up AI startups has come crashing down. But don’t expect healthcare players to slow down their AI investments in 2023.

Frustration with healthcare is universal: A new survey reveals consumers in six major economies aren’t satisfied with their healthcare system.

CVS-Oak Street rumored deal is a Medicare Advantage play: The retailer could soon be placing a big bet on value-based primary care. Is it enough to match its healthcare rivals?

Over the past year, retail has pushed further into healthcare for two reasons: more customers and more money. The usual suspects (e.g., CVS, Walgreens, and Rite Aid) are all making investments in their healthcare offerings, but Amazon is on their heels.